Agenus Inc. Profile Avatar - Palmy Investing

Agenus Inc.

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human a…

Biotechnology
US, Lexington [HQ]

Cash Flow Statements

Loading...
End of AGEN's Analysis
CIK: 1098972 CUSIP: 00847G705 ISIN: US00847G7051 LEI: - UEI: -
Secondary Listings
AGEN has no secondary listings inside our databases.